Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Microbiome
|
April 23, 2021
An atlas of the tissue and blood metagenome in cancer reveals novel links between bacteria, viruses and cancer
Sven Borchmann
Hematology. American Society of Hematology. Education Program
|
December 9, 2022
Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann
Expert Review of Hematology
|
March 21, 2020
An update on disease biomarkers for Hodgkin lymphoma
Melita Cirillo, Sven Borchmann
Current Opinion in Oncology
|
July 12, 2017
The genetics of Hodgkin lymphoma: an overview and clinical implications
Sven Borchmann, Andreas Engert
Leukemia & Lymphoma
|
March 21, 2017
Novel agents in classical Hodgkin lymphoma
Sven Borchmann, Bastian von Tresckow
Scientific Reports
|
November 4, 2017
Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude
Sven Borchmann, Horst Müller, Andreas Engert
Current Opinion in Oncology
|
July 12, 2018
Hodgkin lymphoma in elderly patients
Sven Borchmann, Andreas Engert, Boris Böll
Current Opinion in Oncology
|
July 26, 2016
Current developments in the treatment of early-stage classical Hodgkin lymphoma
Sven Borchmann, Bastian von Tresckow, Andreas Engert
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 19, 2014
Multi-specific antibodies for cancer immunotherapy
Ron D Jachimowicz, Sven Borchmann, Achim Rothe
British Journal of Haematology
|
November 13, 2018
The translational science of hodgkin lymphoma
Melita Cirillo, Sarah Reinke, Wolfram Klapper, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Microbiome
|
April 23, 2021
An atlas of the tissue and blood metagenome in cancer reveals novel links between bacteria, viruses and cancer
Sven Borchmann
Hematology. American Society of Hematology. Education Program
|
December 9, 2022
Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann
Expert Review of Hematology
|
March 21, 2020
An update on disease biomarkers for Hodgkin lymphoma
Melita Cirillo, Sven Borchmann
Current Opinion in Oncology
|
July 12, 2017
The genetics of Hodgkin lymphoma: an overview and clinical implications
Sven Borchmann, Andreas Engert
Leukemia & Lymphoma
|
March 21, 2017
Novel agents in classical Hodgkin lymphoma
Sven Borchmann, Bastian von Tresckow
Scientific Reports
|
November 4, 2017
Hodgkin Lymphoma has a seasonal pattern of incidence and mortality that depends on latitude
Sven Borchmann, Horst Müller, Andreas Engert
Current Opinion in Oncology
|
July 12, 2018
Hodgkin lymphoma in elderly patients
Sven Borchmann, Andreas Engert, Boris Böll
Current Opinion in Oncology
|
July 26, 2016
Current developments in the treatment of early-stage classical Hodgkin lymphoma
Sven Borchmann, Bastian von Tresckow, Andreas Engert
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 19, 2014
Multi-specific antibodies for cancer immunotherapy
Ron D Jachimowicz, Sven Borchmann, Achim Rothe
British Journal of Haematology
|
November 13, 2018
The translational science of hodgkin lymphoma
Melita Cirillo, Sarah Reinke, Wolfram Klapper, et al.
Page
of 5